Big news from the world of synthetic biology! Pareto, an industry leader in molecular and enzyme design, has just partnered with DNA2.0, Inc., a well-known DNA synthesis and optimization company. Pereto hopes to accelerate the speed of protein design and synthesis using DNA 2.0’s proven engineering capacity.
The amalgamation of two major players with widely different expertise in the synthetic biology space plainly demonstrates the beginnings of a robust bioeconomy.
This partnership helps to vertically integrate the two companies. Pareto’s rational-based design expertise will no longer be bottlenecked by its inability to mutate and synthesize genetic and protein material, thanks to DNA2.0’s ProteinGPS and GeneGPS programs.
As Pareto’s CEO, Jamie Bacher, puts it, "Our deep understanding of the structures of these classes of enzymes, along with a statistical optimization algorithm from DNA2.0 gets us the best of both worlds: rational design and robust enzyme improvement. Through our relationship with DNA2.0, we'll be able to generate completely novel molecules with applicability to flavors and fragrances, cosmetics, and therapeutics."
Pareto’s website invites the public to help it “ignite the molecular revolution”. While only the beginning, the amalgamation of two major players with widely different expertise in the synthetic biology space plainly demonstrates the beginnings of a robust bioeconomy. Using their combined capabilities, they will be able to more quickly and efficiently design and perfect enzymes and biological nano-machinery for both current applications, such as biofuels and medicine, as well as opening the floodgates for futuristic technologies yet to even be imagined.